Artwork
iconShare
 
Manage episode 508204203 series 2900042
Content provided by Xtalks. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Xtalks or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

In this episode of the Xtalks Life Science Podcast, host Ayesha Rashid, speaks with Jeff Glazier, CEO and founding member of General Oncology. General Oncology is focused on advancing innovative therapies that address some of the greatest unmet needs in oncology.

At General Oncology, Jeff has overseen everything from corporate strategy and clinical trial site selection to IP protection and IT infrastructure. He stepped into the role of CEO in August 2024, bringing a vision for translating cutting-edge science into meaningful treatments for patients.

Previously, Jeff co-founded the healthcare technology company ProviderTech LLC and worked as a private equity attorney at Ropes & Gray LLP.

Jeff has a JD from Harvard Law School and an Sc.B. in neuroscience from Brown University.

Tune into the episode to hear Jeff’s perspectives on leadership, innovation and shaping the future of oncology.

For more life science and medical device content, visit the Xtalks Vitals homepage. https://xtalks.com/vitals/
Follow Us on Social Media

Twitter: https://twitter.com/Xtalks
Instagram: https://www.instagram.com/xtalks/
Facebook: https://www.facebook.com/Xtalks.Webinars/
LinkedIn: https://www.linkedin.com/company/xtalks-webconferences
YouTube: https://www.youtube.com/c/XtalksWebinars/featured

  continue reading

226 episodes